Nektar Therapeutics, Inc. (NKTR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO, CA 94158

Nektar Therapeutics develops drug delivery systems meant to improve the performance of a drug molecule or how the drug is delivered (e.g., enabling new dosage form or delivery profile that improves how the therapeutic can treat patients).

Data based on most recent fiscal year report
Market Cap3.944 Billion Shares Outstanding175.92 Million Avg Volume3.264 Million
1-Yr BETA vs S&P TR0.829 Current Ratio17.53 Quick Ratio17.39
View SEC Filings from NKTR instead.

View recent insider trading info

Funds Holding NKTR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NKTR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

74.1 Thousand total shares from 9 transactions

Exercise Derivative Conversion (M)

53.5 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

AJER JEFFREY ROBERT EVP, CHIEF COMMERCIAL OFFICER

  • Officer
65,471 2020-04-01 3

GERGEL IVAN P.

  • Director
0 2020-03-20 0

DOBERSTEIN STEPHEN K

  • Director
0 2020-03-12 3

CHESS ROBERT

  • Director
276,973 2020-03-11 4

MYRIAM CURET EVP & CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-28 2

LABRUCHERIE GIL M SVP, COO & CFO

  • Officer
253,221 2020-02-18 13

ROBIN HOWARD W PRESIDENT & CEO

  • Officer
  • Director
385,281 2020-02-18 9

THOMSEN JILLIAN B. SVP & CHIEF ACCOUNTING OFFICER

  • Officer
174,086 2020-02-18 6

ZALEVSKY JONATHAN CHIEF R&D OFFICER

  • Officer
327,073 2020-02-18 5

KUEBLER CHRISTOPHER A

  • Director
15,977 2020-01-02 0

WHITFIELD ROY A

  • Director
218,250 2019-12-18 2

NORTHCOTT JOHN SVP & CHIEF COMMERCIAL OFFICER

  • Officer
200,000 2019-12-02 2

LINGNAU LUTZ

  • Director
26,700 2019-09-27 3

GREER R SCOTT

  • Director
151,583 2019-09-25 1

EASTHAM KARIN

  • Director
15,000 2019-09-25 1

LORIANNE MASUOKA K. CHIEF MEDICAL OFFICER

  • Officer
0 2019-08-21 0

NICHOLSON JOHN SVP & CHIEF OPERATING OFFICER

  • Officer
162,759 2019-08-16 2

CHOWRIRA BHARAT M

  • Director
10,000 2019-07-01 0

HORA MANINDER SVP PHARMA DEV & MFG OPS

  • Officer
94,694 2019-05-16 1

WINGER DENNIS L

  • Director
47,750 2018-08-17 0

HUH HOYOUNG

  • Director
0 2018-06-22 0

KRIVULKA JOSEPH J

  • Director
82,000 2017-09-19 0

BROWN MICHAEL A/CA CEO

  • Officer
  • Director
414,016 2016-06-01 0

WANG SUSAN

  • Director
9,887 2016-01-25 0

PATTON JOHN STUART

  • Director
179,876 2014-08-19 0

MEDVE ROBERT SVP & CHIEF MEDICAL OFFICER

  • Officer
0 2014-02-05 0

GHOSH RINKO CHIEF BUSINESS OFFICER

  • Officer
0 2013-02-06 0

MOREADITH RANDALL W SVP DRUG DEVELOPMENT

  • Officer
0 2009-02-23 0

LERNER IRWIN

  • Director
13,200 2009-01-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

CHESS ROBERT - Director

2020-03-11 M 8,000 d 24,000 276,973.00 direct

CHESS ROBERT - Director

2020-03-11 M 8,000 $9.24 d 284,973 276,973.00 direct

CHESS ROBERT - Director

2020-03-11 S 1,200 $17.41 d 276,973 276,973.00 direct

CHESS ROBERT - Director

2020-03-11 S 6,800 $16.68 d 278,173 276,973.00 direct

THOMSEN JILLIAN B. - Officer SVP & CHIEF ACCOUNTING OFFICER

2020-02-18 S 1,394 $22.35 d 174,086 174,086.00 direct

LABRUCHERIE GIL M - Officer SVP, COO & CFO

2020-02-18 S 5,938 $22.35 d 253,221 253,221.00 direct

ZALEVSKY JONATHAN - Officer CHIEF R&D OFFICER

2020-02-18 S 4,774 $22.35 d 327,073 327,073.00 direct

ROBIN HOWARD W - Director - Officer PRESIDENT & CEO

2020-02-18 S 8,448 $22.35 d 384,871 385,281.00 direct

CHESS ROBERT - Director

2020-02-12 S 3,599 $23.72 d 276,973 276,973.00 direct

CHESS ROBERT - Director

2020-02-12 S 4,401 $23.32 d 280,572 276,973.00 direct

CHESS ROBERT - Director

2020-02-12 M 8,000 d 32,000 276,973.00 direct

CHESS ROBERT - Director

2020-02-12 M 8,000 $9.24 d 284,973 276,973.00 direct

THOMSEN JILLIAN B. - Officer SVP & CHIEF ACCOUNTING OFFICER

2020-02-06 M 37,500 $7.21 a 212,980 175,480.00 direct

THOMSEN JILLIAN B. - Officer SVP & CHIEF ACCOUNTING OFFICER

2020-02-06 M 37,500 d 0 175,480.00 direct

THOMSEN JILLIAN B. - Officer SVP & CHIEF ACCOUNTING OFFICER

2020-02-06 S 37,500 $22.78 d 175,480 175,480.00 direct

Elevate your investments